Functional responses to the cannabinoid agonist WIN 55,212-2 in neonatal rats of both genders: Influence of weaning

Pharmacology Biochemistry and Behavior

Volumn 78, Issue 3, 2004, Pages 593-602

  Borcel, Erika ^a   Pérez Alvarez, Laura ^a   De Ceballos, María L ^b   Ramirez, Belén G ^b   Marco, Eva Ma ^a   Fernández, Beatriz ^a   Rubio, Marina ^a   Guaza, Carmen ^b   Viveros, Ma Paz ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO CAJAL   (Spain)

Author keywords

Cannabinoid agonist stimulated 35S GTP S binding; Corticosterone; Nociception; Open field; Rat; Weaning; WIN 55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR AGONIST; CORTICOSTERONE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); SULFUR 35;

ANIMAL TISSUE; BEHAVIOR; BINDING AFFINITY; BIOCHEMISTRY; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MEGADOSE; EXPERIMENTAL TEST; FEMALE; HORMONE RELEASE; ISOTOPE LABELING; LATENT PERIOD; MALE; NEWBORN; NOCICEPTION; NONHUMAN; OPEN FIELD BEHAVIOR; PAIN THRESHOLD; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SEX DIFFERENCE; STIMULATION; TAIL IMMERSION TEST; WEANING;

ANIMALS; ANIMALS, NEWBORN; CORTICOSTERONE; FEMALE; GUANOSINE TRIPHOSPHATE; MALE; MORPHOLINES; NAPHTHALENES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SEX CHARACTERISTICS; WEANING;

ANIMALIA;

EID: 3142528205     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2004.02.020     Document Type: Conference Paper

References (34)

1. Berrendero F., Maldonado R. Involvement of the opioid system in the anxiolytic-like effects induced by Delta (9)-tetrahydrocannabinol. Psychopharmacology. 163:2002;111-117
2. Berrendero F., Sepe N., Ramos J.A., Di Marzo V., Fernández-Ruiz J.J. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse. 33:1999;181-191
3. Blass E.M. Behavioral and physiological consequences of suckling in rat and human newborns. Acta Paediatr. Suppl. 397:1994;71-76
4. Chaperon F., Thiébot M.-H. Behavioral effects of cannabinoid agents in animals. Crit. Rev. Neurobiol. 13:1999;243-281
5. Di Marzo V., Sepe N., De Petrocellis L., Berger A., Crozier G., Fride E., et al. Trick or treat from food endocannabinoids? Nature. 396:1998;636-637
6. 2 receptor-mediated actions of anandamide in mouse brain. J. Neurochem. 75:2000;2434-2444
7. Fernández B., Antelo M.T., Kitchen I., Viveros M.P. Effects of neonatal naltrindole treatment on antinociceptive and behavioral responses to μ and κ agonists in rats. Pharmacol. Biochem. Behav. 62:1999;145-149
8. Fernández-Ruiz J., Berrendero F., Hernández M.L., Romero J., Ramos J.A. Role of endocannabinoids in brain development. Life Sci. 65:1999;725-736
9. Fernández-Ruiz J., Berrendero F., Hernández M.L., Ramos J.A. The endogenous cannabinoid system and brain development. Trends Neurosci. 23:2000;14-20
10. 1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain. 92:2001;91-100
11. Fride E., Mechoulam R. Developmental aspects of anandamide: ontogeny of response and prenatal exposure. Psychoneuroendocrinology. 21:1996;157-172
12. 9-tetrahydrocannabinol in mice. Dev. Brain Res. 95:1996;131-134
13. Fride E., Shohami E. The endocannabinoid system: function in survival of the embryo, the newborn and the neuron. NeuroReport. 13:2002;1833-1841
14. Fride E., Ginzburg Y., Breuer A., Bisogno T., Di Marzo V., Mechoulam R. Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. Eur. J. Pharmacol. 419:2001;207-214
15. Goody R.J., Kitchen I. Influence of maternal milk on functional activation of delta-opioid receptors in postnatal rats. J. Pharmacol. Exp. Ther. 296:2001;744-748
16. Kirkham T.C., Williams C.M. Synergistic effects of opioid and cannabinoid antagonists on food intake. Psychopharmacology. 153:2001;267-270
17. Kitchen I., Mcdowell J., Winder C., Wilson J.M. Low level lead exposure alters morphine antinociception in neonatal rats. Toxicol. Lett. 22:1984;119-123
18. Kitchen I., Leslie F.M., Kelly M., Barnes R., Crook T.J., Hill R.G., et al. Development of delta-opioid receptor subtypes and the regulatory role of weaning: radioligand binding, autoradiography and in situ hybridation studies. J. Pharmacol. Exp. Ther. 275:1995;1597-1607
19. Laviola G., Macri S., Morley-Fletcher S., Adriani W. Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. Neurosci. Biobehav. Rev. 27:2003;19-31
20. 9-tetrahydrocannabinol in rats. Brain Res. 839:1999;173-179
21. Manzanares J., Corchero J., Romero J., Fernández-Ruiz J.J., Ramos J.A., Fuentes J.A. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol. Sci. 20:1999;287-294
22. Marín S., Marco E., Biscaia M., Fernández B., Rubio M., Guaza C., et al. Involvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55, 940 in male rats. Pharmacol. Biochem. Behav. 74:2003;649-656
23. 8-tetrahydrocannabinol- dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats. Eur. J. Pharmacol. 344:1998;77-86
24. Mcgregor I.S., Dastur F.N., Mclellan R.A., Brown R.E. Cannabinoid modulation of rat pup ultrasonic vocalizations. Eur. J. Pharmacol. 313:1996;43-49
25. Mclusky N.J., Naftolin F. Sexual differentiation of the central nervous system. Science. 211:1981;1294-1303
26. 9- tetrahydrocannabinol. An ontogenic study in Wistar rats. Psychopharmacology. 116:1994;414-422
27. Ramos J.A., De Miguel R., Cebeira M., Hernandez M., Fernandez-Ruiz J. Exposure to cannabinoids in the development of endogenous cannabinoid system. Neurotox. Res. 4:2002;363-372
28. Rodriguez de Fonseca F., Ramos J.A., Bonin A., Fernández-Ruiz J.J. Presence of cannabinoid binding sites in the brain from early postnatal ages. NeuroReport. 4:1993;135-138
29. Romero J., García-Palomero E., Berrendero F., García-Gil L., Hernández M.L., Ramos J.A., et al. Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse. 26:1997;317-323
30. Romero E.M., Fernández B., Sagredo O., Gomez N., Urigüen L., Guaza C., et al. Antinociceptive, behavioural and neuroendocrine effects of CP 55, 940 in young rats. Dev. Brain Res. 136:2002;85-92
31. Terranova M.L., Laviola G. Delta-opioid modulation of social interactions in juvenile mice weaned at different ages. Physiol. Behav. 73:2001;393-400
32. Viveros M.P., Hernández R., Martinez I., González P. Effects of social isolation and crowding upon adrenocortical reactivity and behavior in the rat. Rev. Esp. Fisiol. 44:1988;315-322
33. Wenger T., Jamali K.A., Juaneda C., Leonardelli J., Tramu G. Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus. Biochem. Biophys. Res. Commun. 237:1997;724-728
34. Williamson E.M., Evans F.J. Cannabinoids in clinical practice. Drugs. 60:2000;1303-1314